Healthcare
Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension
$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official...
Replimune Reports Promising New Data for Acral Melanoma Treatment at ESMO 2025
RP1 combined with nivolumab shows meaningful tumor response in rare and aggressive skin cancer Replimune Group (REPL), a clinical-stage biotechnology...
Praxis Announces Breakthrough Phase 3 Results for Ulixacaltamide in Essential Tremor Treatment
Positive data from Essential3 program marks major step toward first targeted therapy for millions living with essential tremor Praxis Precision...
Genprex Shares Gain as Positive Preclinical Lung Cancer Data to Be Presented at Global Oncology Conference
REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that...
Wall Street’s Biggest Analyst Calls Today: Upgrades Favor Tech, Downgrades Hit Industrials and Healthcare
Semiconductor optimism drives bullish calls on AMD and Monolithic Power while managed care stocks come under pressure Wall Street analysts...
J&J Eyes Biotech Buyout to Strengthen Immunology Pipeline
Prospective acquisition of Protagonist Therapeutics centers on oral drug for immune diseases Johnson & Johnson (JNJ) is reportedly in active...
Envoy Medical Advances to Final Stage of FDA Trial for Fully Implanted Cochlear Implant
Positive early results accelerate timeline and reduce capital needs by up to $15 million Envoy Medical (COCH), a Minnesota-based hearing...
Drugmakers Gain as Markets Digest Trump’s Proposed 100% Pharma Tariffs
Exemptions for U.S. plant construction and existing expansion plans temper immediate fallout, but uncertainty remains for smaller firms Shares of...
Kenvue Rebounds After Tylenol Autism Claims Spark Market Jitters
Analysts cite lack of new scientific evidence as shares recover from record low Kenvue (KVUE) shares rose 6% on Tuesday,...
NeuroNOS Earns FDA Orphan Drug Designation for Glioblastoma Therapy
BA-101 aims to address urgent unmet needs in one of the deadliest brain cancers NeuroNOS, a subsidiary of Beyond Air...
